000 01094 a2200301 4500
005 20250515093906.0
264 0 _c20080123
008 200801s 0 0 eng d
022 _a1468-201X
024 7 _a10.1136/hrt.2007.132894
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChung, H
245 0 0 _aAlteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance.
_h[electronic resource]
260 _bHeart (British Cardiac Society)
_cDec 2007
300 _a1616-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aStroke
_xdrug therapy
650 0 4 _aTechnology Assessment, Biomedical
650 0 4 _aTissue Plasminogen Activator
_xtherapeutic use
700 1 _aRefoios Camejo, R
700 1 _aCamejo, R R
700 1 _aBarnett, D
773 0 _tHeart (British Cardiac Society)
_gvol. 93
_gno. 12
_gp. 1616-7
856 4 0 _uhttps://doi.org/10.1136/hrt.2007.132894
_zAvailable from publisher's website
999 _c17520720
_d17520720